Fresh analysis indicates that patients who stop using blockbuster slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt traditional lifestyle regimens.
Published data in a prominent health publication demonstrates that while obese people frequently drop substantial amounts of their body weight while on the medication, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users using these drugs must be aware of the risk of rapid weight regain when the medication ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery suggests a return to starting weight in about 18 months.
Weighing Approaches
The analysis, which reviewed dozens of studies involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.
Scientists emphasize that people who lose weight through lifestyle changes alone typically experience a less rapid weight regain—around 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists propose the mechanism of the jabs is key to understanding the heightened regain.
These medications mimic a body's own chemical called GLP-1, which helps regulate hunger.
"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the system to produce less of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication means hunger is unsuppressed, making overeating much more probable."
A Chronic Condition?
Medical guidelines advise the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals say that, given the likelihood of relapse, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who state that the results "emphasize the chronic nature of obesity," akin to managing diseases like diabetes.
User Testimonies
Users who have discontinued the jabs describe a powerful return of appetite.
"It felt as if something activating and I was suddenly ravenous," said a patient.
The struggle is worsened if users have not adopted sustainable lifestyle or habit changes during therapy.
Significant Use
Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Use is higher among women compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while these medications are potent agents for weight loss, they are not a magic fix and long-term success likely depends on ongoing lifestyle changes.
